Vaxxinity, Inc.

VAXX · OTC
Analyze with AI
12/31/2023
9/30/2023
6/30/2023
3/31/2023
Operating Activities
Net Income-$11,392-$13,144-$13,977-$18,421
Dep. & Amort.$456$666$526$586
Deferred Tax$0-$350-$872$0
Stock-Based Comp.$1$1,769$2,433$2,225
Change in WC-$1,670-$2,138-$687-$4,048
Other Non-Cash$760$13$419-$393
Operating Cash Flow-$11,845-$13,184-$12,158-$20,051
Investing Activities
PP&E Inv.-$414-$127-$90-$0
Net Acquisitions$0$5,972$0$0
Inv. Purchases-$20,355-$24,999$0-$18,588
Inv. Sales/Matur.$20,362$19,027$26,700$27,500
Other Inv. Act.$0-$5,972$27-$172
Investing Cash Flow-$407-$6,099$26,610$8,740
Financing Activities
Debt Repay.-$314-$435-$268-$577
Stock Issued$1$56$393$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$56$394$3
Financing Cash Flow-$313-$379$126-$574
Forex Effect$0$0$0$0
Net Chg. in Cash-$12,565-$19,662$14,578-$11,885
Supplemental Information
Beg. Cash$17,601$37,263$22,685$34,570
End Cash$5,036$17,601$37,263$22,685
Free Cash Flow-$12,259-$13,311-$12,248-$20,223
Vaxxinity, Inc. (VAXX) Financial Statements & Key Stats | AlphaPilot